Close Menu
    East Timor TimesEast Timor Times
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    East Timor TimesEast Timor Times
    Home » Nationwide shock as CVS and Walgreens begin abortion pill sales
    Health

    Nationwide shock as CVS and Walgreens begin abortion pill sales

    March 4, 2024
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Two of the largest pharmacy chains in the United States, CVS and Walgreens, have announced plans to make the abortion pill, mifepristone, available for sale across the country. This decision marks a significant shift in reproductive healthcare accessibility. Both CVS and Walgreens disclosed on Friday that they have obtained Risk Evaluation and Mitigation Strategy (REMS) certifications from the Food and Drug Administration (FDA). These certifications are crucial prerequisites for pharmacies and prescribers to dispense mifepristone, emphasizing safety protocols and risk assessment.

    Nationwide shock as CVS and Walgreens begin abortion pill sales

    The REMS program, mandated by the FDA for drugs with substantial safety concerns, aims to ensure that the benefits of the medication outweigh potential risks. However, critics argue that the requirement for mifepristone under REMS lacks scientific basis and restricts access to the drug, fueling ongoing debates surrounding reproductive rights. In response to inquiries, CVS issued a statement to The Hill, confirming their readiness to dispense mifepristone.

    While currently not available in any of their pharmacies, CVS plans to initiate the distribution process soon, starting with states where legal regulations permit. The pharmacy giant aims for a gradual expansion across states, ensuring compliance with local laws and regulations. Similarly, a spokesperson for Walgreens affirmed the completion of the FDA certification process for mifepristone dispensation. They outlined a phased rollout strategy, initially targeting select locations in states such as New York, Pennsylvania, Massachusetts, California, and Illinois.

    Walgreens also indicated plans to offer the generic form of the pill in the future, enhancing affordability and accessibility for patients. US President, Joe Biden hailed the announcement, highlighting its significance in expanding healthcare options for women. He emphasized the importance of ensuring access to medication abortion through certified pharmacy chains, particularly amid ongoing challenges to reproductive rights nationwide.

    However, mifepristone’s FDA approval has been embroiled in legal disputes, with a federal lawsuit challenging its status as an abortifacient. While a panel of judges upheld the approval, they reversed federal measures aimed at broadening access to the drug. The Department of Justice has petitioned the Supreme Court to reconsider this decision, setting the stage for a pivotal legal showdown.

    The Supreme Court has scheduled arguments on the case, with a hearing slated for March 26, raising the stakes for reproductive rights advocates and healthcare providers alike. This development underscores the intersection of healthcare, legal, and political realms, shaping the landscape of reproductive rights in the United States. As the nation awaits further legal proceedings, the availability of mifepristone through major pharmacy chains represents a significant milestone in ensuring equitable access to reproductive healthcare services.

    Related Posts

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Ebola cases top 11,200 as Africa CDC warns of record outbreak

    November 16, 2026

    Yellow fever kills 18 across nine African nations, WHO says

    November 7, 2026

    Dengue kills 173 in October as Bangladesh toll climbs to 418

    November 2, 2026

    Ebola deaths in DR Congo reach 5,340, fatality rate at 51.6%

    November 2, 2026

    Ebola death toll in DR Congo nears 4,900 as cases pass 10,000

    October 28, 2026
    Latest News

    Dubai Airports expects over 70 million guests in 2026

    November 18, 2026

    – Dubai Airports expects Dubai International to welcome more than 70 million guests in 2026 as airlines return and its network rebuilds. The airport handled 50.4 million guests in the first nine months of the year, the operator said. That

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    Over 9 million visitors lift Tunisia tourism income 3.4%

    November 17, 2026

    Sheikh Mohamed receives Venezuela’s Delcy Rodríguez in Abu Dhabi

    November 17, 2026

    Etihad plans seven weekly Calgary flights as demand grows

    November 17, 2026

    Ebola cases top 11,200 as Africa CDC warns of record outbreak

    November 16, 2026

    Sheikh Mohamed and Ramos-Horta talk trade, energy and ASEAN

    November 16, 2026
    © 2026 East Timor Times | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.